That’s what the autoimmune disease lupus does, 1 and when it strikes, it can cause significant symptoms, including extreme ...
AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector, the SAPHNELO Pen , for the treatment of adult patients with systemic ...
AstraZeneca’s Saphnelo approved in US for subcutaneous self-administration as a new autoinjector to treat systemic lupus erythematosus: Cambridge, UK Tuesday, April 28, 2026, 10 ...
Objectives To assess indirect costs (IDC) due to lost productivity in paid/unpaid labour, stratified by sex, in a national ...
Chiropractors are my kind of people.”RFK Jr. to ChiropractorsNot certain who was more insulted, although it appears both ...
Throughout the month of May, the Lupus Foundation of America is encouraging people living with lupus, friends, family members and partners to be loud and use their voices more than ever before to Make ...
Until biomarkers that can predict treatment response emerge, early and aggressive treatment is recommended in lupus nephritis ...
Fatimah Shepherd’s kidneys were compromised, and pregnancy could send her into kidney failure. By Roni Caryn Rabin ...
The FDA has approved a self-administered autoinjector form of anifrolumab for the treatment of systemic lupus erythematosus, ...
The dismissal of this chronic condition is a common pain point for the nearly 10% of women who have it. In a society that ...
AstraZeneca's Saphnelo (anifrolumab) has been approved in the US for self-administration as a once-weekly autoinjector, the Saphnelo Pen, for the ...
Since she was 8 years old, Nancy Mize Gonzalez dreamed of becoming a concert pianist. She practiced for hours a day every day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results